XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Collaboration Agreements - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Apr. 30, 2020
Dec. 31, 2019
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Revenue recognized $ 1,528,000 $ 3,740,000    
Collaboration and License Agreement | Hanmi Pharmaceutical Co., LTD        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Upfront and near-term milestone payment 10,000,000 10,000,000   $ 10,000,000
Upfront fee receivable 4,000,000 4,000,000   4,000,000
Milestone payment 6,000,000 6,000,000 $ 6,000,000  
Revenue recognized 1,500,000 3,700,000    
Deferred revenue $ 6,300,000 $ 6,300,000   4,000,000
Collaboration and License Agreement | Hanmi Pharmaceutical Co., LTD | Maximum        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Contingent payments upon Achievement of specified milestones       $ 108,000,000